Increased Transcutaneous Oxygen Tension in the Skin Dorsum Over the Foot in Patients With Diabetic Foot Disease in Response to the Topical Use of an Emulsion of Hyperoxygenated Fatty Acids
Restricted accessOtherFirst published online December, 2009
Increased Transcutaneous Oxygen Tension in the Skin Dorsum Over the Foot in Patients With Diabetic Foot Disease in Response to the Topical Use of an Emulsion of Hyperoxygenated Fatty Acids
The aim of this study was to examine changes in the skin over the feet of patients with diabetic foot syndrome after local application of a product containing hyperoxygenated fatty acids (HOFAs) by measuring transcutaneous oxygen. In 64 patients, transcutaneous oxygen pressure (TcPo2) was measured on days 0, 7, 30, 60, and 90 of the study. Foot skin dryness, shedding, and skin color were also assessed using a clinical score. The patients were grouped on the basis of initial levels of transcutaneous oxygen; group 1 comprised patients with TcPo 2 >30 mm Hg and group 2 comprised patients with TcPo2 <30 mm Hg on the skin over the dorsum of the feet. Increases in local oxygenation values were observed at a local level in group 2 patients after 30 days of treatment. Skin trophism showed clinical improvement in all patients and these observations may be attributed to improved local microcirculation.
Boulton AJ, Vileikyte L., Ragnarson-Tennvall G., Apelqvist J.The global burden of diabetic foot disease. Lancet . 2005;366: 1719-1724.
2.
Bild DE, Selby JV, Sinnock P., Browner WS, Braveman P., Showstack JALower-extremity amputation in people with diabetes. Epidemiology and prevention . Diabetes Care. 1989;12: 24-31.
3.
Abbott CA, Carrington AL, Ashe H., et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort . Diabet Med. 2002;19:377-84.
4.
Schramm JC, Dinh T., Veves A.Microvascular changes in the diabetic foot. Int J Low Extrem Wounds. 2006;5:149-159.
5.
Williams DT , Price P., Harding KGThe influence of diabetes and lower limb arterial disease on cutaneous foot perfusion. J Vasc Surg . 2006;44:770-775.
6.
Goldemberg S.Alex M., Joshi RA, Blumenthal HTNon atheromatous peripheral vascular diseases of the lower extremity in diabetes mellitus. Diabetes. 1959;8:261-273.
7.
Mayrovitz HN , Larsen PBFunctional microcirculatory impairment: a possible source of reduced skin oxygen tension in human diabetes mellitus . Microvasc Res. 1996;52:115-126.
8.
Rendell M., Bamisedun O.Diabetic cutaneous microangiopathy. Am J Med. 1992;93:611-618.
9.
Regoli M., Bendayan M.Alterations in the expression of the alpha 3 beta 1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus . Diabetologia. 1997;40:15-22.
10.
Berg UB, Torbjornsdotter TB, Jaremko G., Thalme B.Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM. Diabetologia . 1998;41:1047-1056.
11.
Huijberts MS , Schaper NC, Schalkwijk CGAdvanced glycation end products and diabetic foot disease. Diabetes Metab Res Rev. 2008 ;24(suppl 1):S19-S24.
12.
Karabouta Z. , Barnett S., Shield JP, Ryan FJ, Crowne ECPeripheral neuropathy is an early complication of type 2 diabetes in adolescence. Pediatr Diabetes. 2008;9:110-114.
13.
Kamal K., Du W., Mills I., Sumpio BEAntiproliferative effect of elevated glucose in human microvascular endothelial cells. J Cell Biochem. 1998;71:491-501.
14.
Colberg SR, Azoury KR, Parson HK, Vinik AIExercise status affects skin perfusion via prostaglandin, nitric oxide, and EDHF pathways in diabetes. Microvasc Res. 2009;77:120-124.
15.
Obrosova IGDiabetes and the peripheral nerve [published online ahead of print November 13, 2008]. Biochim Biophys Acta. doi:10.1016/j.bbadis.2008.11.005.
16.
Winkley K., Stahl D., Chalder T., Edmonds ME, Ismail K.Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J Diabetes Complications. 2007;21:341-349.
17.
Mathieu D., Mani R.A review of the clinical significance of tissue hypoxia measurements in lower extremity wound management. Int J Low Extrem Wounds . 2007;6:273-283.
18.
Segovia GT, Javares CT, Barahona M., Verdu SJCaring for perilesional skin or skin having a lesion risk. Rev Enferm. 2007;30(10):43-48.
19.
Torra i Bou JE, Segovia Gomez T., Verdu Soriano J., Nolasco Bonmati A., Rueda Lopez J., Arboix i Perejamo M.The effectiveness of a hyperoxygenated fatty acid compound in preventing pressure ulcers. J Wound Care . 2005;14:117-121.
20.
Declair V.The usefulness of topical application of essential fatty acids (EFA) to prevent pressure ulcers. Ostomy Wound Manage. 1997 ;43(5):48-52.
21.
Armstrong DG , Lavery LA, Vela SA, Quebedeaux TL, Fleischli JGChoosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med. 1998;158:289-292.
22.
Kalani M., Brismar K., Fagrell B., Ostergren J., Jorneskog G.Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care. 1999 ;22:147-151.
23.
Incandela L. , Belcaro G., Cesarone MR, De Sanctis MT, Griffin M.Microvascular alterations in diabetic microangiopathy: topical treatment with Essaven gel-a placebo-controlled, randomized study . Angiology. 2001;52(suppl 3):S35-S41.
24.
Cesarone MR, Incandela L., Belcaro G., De Sanctis MT, Ricci A., Griffin M.Two-week topical treatment with Essaven gel in patients with diabetic microangiopathy-a placebo-controlled, randomized study. Angiology . 2001;52(suppl 3):S43-S48.
25.
Cesarone MR, Belcaro G., Rohdewald P., et al. Improvement of diabetic microangiopathy with pycnogenol: a prospective, controlled study. Angiology. 2006;57:431-436.
26.
Cobb J., Claremont D.Noninvasive measurement techniques for monitoring of microvascular function in the diabetic foot. Int J Low Extrem Wounds. 2002;1:161-169.
27.
Samoilova KA , Zhevago NA, Menshutina MA, Grigorieva NBRole of nitric oxide in the visible light-induced rapid increase of human skin microcirculation at the local and systemic level: I. Diabetic patients. Photomed Laser Surg. 2008;26:433-442.
28.
Weck M., Rietzsch H., Lawall H., Pichlmeier U., Bramlage P., Schellong S.Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulceration. Thromb Haemost. 2008;100:475-482.
29.
Kalani M., Silveira A., Blombäck M., et al. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers. Thromb Res. 2007;120:653-661.
30.
Krishnan ST , Baker NR, Carrington AL, Rayman G.Comparative roles of microvascular and nerve function in foot ulceration in type 2 diabetes . Diabetes Care . 2004;27:1343-1348.
